Journal
AMERICAN JOURNAL OF TRANSPLANTATION
Volume 11, Issue 6, Pages 1123-1130Publisher
WILEY
DOI: 10.1111/j.1600-6143.2011.03493.x
Keywords
Donor-derived; donor screening; infection; malignancy; patient safety; transplantation
Categories
Ask authors/readers for more resources
Several recent donor-to-recipient disease transmissions have highlighted the importance of this rare complication of solid organ transplantation. The epidemiology of donor-derived disease transmissions in the United States has been described through reports to the Organ Procurement and Transplant Network (OPTN); these reports are reviewed and categorized by the ad hoc Disease Transmission Advisory Committee (DTAC); additional data comes through the published literature. From these reports, it is possible to estimate that donor-derived disease transmission complicates less than 1% of all transplant procedures but when a transmission occurs, significant morbidity and mortality can result. Only through continued presentation of the available data can continuous quality improvements be made. As the epidemiology of donor-derived disease transmission has become better understood, several groups have been working on methods to further mitigate this risk.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available